A Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)
Clinical trial NCT03013218 · COMPLETED
Trial details
- NCT number
- NCT03013218
- Sponsor
- ALX Oncology Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-03
- Primary completion
- 2022-02-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.